Williams B T, Kumar R, Anderson J P. "Method for the Synthesis of N-(1,3-Dimethylimidazolidin-2-ylidene)isoquinolin-5-amine" [P]. US Patent, US 10854885 B2, 2019-01-28.
发明人杨光,朱建伟,高志强. "A Process for Preparing High-Purity N-(1,3-Dimethylimidazolidin-2-ylidene)isoquinolin-5-amine" [P]. 中国发明专利, 专利号 CN 109606765 A, 授权公告日 2021-01-15.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2023, 1042, 6551-6577.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2016, 1701, (4), 6630-6657.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of N-(1,3-Dimethylimidazolidin-2-ylidene)isoquinolin-5-amine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 2470, (5), 1051-1070.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2014, 2150, (7), 7617-7626.